CVE:DMT Small Pharma (DMT) Stock Price, News & Analysis → Write this ticker symbol down… (From StocksToTrade) (Ad) Free DMT Stock Alerts C$0.15 -0.01 (-6.25%) (As of 10/20/2023) Add Compare Share Share Today's RangeC$0.15▼C$0.1650-Day RangeC$0.15▼C$0.1552-Week RangeC$0.06▼C$0.22Volume1.89 million shsAverage Volume296,159 shsMarket CapitalizationC$50.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsHeadlinesInsider TradesStock AnalysisEarningsHeadlinesInsider Trades Get Small Pharma alerts: Email Address Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… About Small Pharma Stock (CVE:DMT)Small Pharma Inc., a biotechnology company, focuses on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions. Its clinical program is based on N,N, dimethyltryptamine, a naturally occurring psychoactive molecule. The company's product includes SPL026, which is in clinical Phase IIa for the treatment of major depressive disorder; and SPL028, an injectable formulation of deuterated DMT, which is in Phase 1 clinical trial, as well as SPL801B, an oral dosage. Its preclinical stage programs include SPL029, an oral formulation of a tryptamine to treat depressive disorder. The company is headquartered in London, the United Kingdom. As of October 23, 2023, Small Pharma Inc. operates as a subsidiary of Cybin Inc.Read More DMT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DMT Stock News HeadlinesMay 24, 2024 | americanbankingnews.comSmall Pharma (CVE:DMT) Trading Down 6.3%April 26, 2024 | msn.comA shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact with proteinsApril 26, 2024 | msn.comTech bros love talking about microdosing - but the legality of psychedelics is a messy grey areaApril 10, 2024 | forbes.comNavigating The Cookieless Era: How Pharma Adapts To Continual DisruptionApril 8, 2024 | msn.comFSD Pharma receives Nasdaq notification regarding minimum bid price deficiencyMarch 26, 2024 | finance.yahoo.comJuvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and PembertonMarch 13, 2024 | msn.comLGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilitiesMarch 9, 2024 | businessinsider.comPharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnificent 7February 27, 2024 | msn.comPharma major Roche launches breakthrough therapy to treat Multiple Sclerosis in IndiaFebruary 20, 2024 | msn.comTrxade sells online pharma marketplace, stock rallies 90%February 15, 2024 | msn.comMedford Massachusets Move To Decriminalize Psychedelics Has Statewide Reform ImplicationsDecember 5, 2023 | msn.comSmall Pharma Tackles Major Depression with Potentially Game Changing Psychedelic TherapyOctober 23, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - DMTOctober 20, 2023 | benzinga.comSmall Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT BusinessOctober 20, 2023 | finanznachrichten.deSmall Pharma Inc.: Small Pharma Reports Fiscal Second Quarter 2024 HighlightsOctober 17, 2023 | theglobeandmail.comClosing Bell: Small Pharma Inc down on Monday (DMT)October 12, 2023 | markets.businessinsider.comSmall Pharma Announces Voting Results from Annual General and Special Meeting of ShareholdersOctober 3, 2023 | theglobeandmail.comClosing Bell: Small Pharma Inc up on Monday (DMT)September 28, 2023 | theglobeandmail.comClosing Bell: Small Pharma Inc down on Wednesday (DMT)August 28, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - DMTAugust 26, 2023 | theglobeandmail.comClosing Bell: Small Pharma Inc up on Friday (DMT)August 25, 2023 | theglobeandmail.comClosing Bell: Small Pharma Inc down on Thursday (DMT)July 28, 2023 | finanznachrichten.deSmall Pharma Inc.: Small Pharma Reports Fiscal First Quarter 2024 HighlightsJuly 28, 2023 | finance.yahoo.comSmall Pharma Reports Fiscal First Quarter 2024 HighlightsJuly 5, 2023 | msn.comSmall Pharma Implements Costs Cut: New R&D Strategy And Management Team ChangeSee More Headlines Receive DMT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Small Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:DMT CUSIPN/A CIKN/A Webwww.smallpharma.co.uk Phone44 78 1212 1944FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-19,310,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-116.90% Return on Assets-66.00% Debt Debt-to-Equity Ratio5.95 Current Ratio2.63 Quick Ratio6.28 Sales & Book Value Annual SalesC$-1,162.00 Price / Sales-43,343.80 Cash FlowC$0.13 per share Price / Cash Flow1.13 Book ValueC$0.03 per share Price / Book5.00Miscellaneous Outstanding Shares335,770,000Free FloatN/AMarket CapC$50.37 million OptionableNot Optionable Beta0.86 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. George TzirasCEO & Non-Independent DirectorMr. David SteelChief Financial OfficerDr. Carol RoutledgeChief Scientific & Medical OfficerMs. Marie Claire Layzell (Age 46)Chief Manufacturing & Development Officer & Director Comp: $457.93kDr. Alastair James Riddell M.D. (Age 74)M.Sc., MBChB, MFPM, MRCGP, Ph.D., Chief Operating Officer Ms. Jenny MaguireHead of Brand & CommunicationsMs. Emma HodgeHead of Intellectual PropertyMr. Richard M. Kimel HBA (Age 56)LLB, Corporate Secretary Ms. Sarah HamiltonGroup Financial ControllerMr. Jim RennieDirector of Development and Member of Scientific & Advisory BoardMore ExecutivesKey CompetitorsMedicenna TherapeuticsTSE:MDNABriaCell TherapeuticsCVE:BCTImmunoPrecise AntibodiesCVE:IPAOncolytics BiotechTSE:ONCScythian BiosciencesCVE:SCYBView All CompetitorsInsidersPeter David RandsSold 638,000 sharesTotal: C$43,511.60 ($0.07/share)View All Insider Transactions DMT Stock Analysis - Frequently Asked Questions How have DMT shares performed in 2024? Small Pharma's stock was trading at C$0.15 at the beginning of 2024. Since then, DMT stock has increased by 0.0% and is now trading at C$0.15. View the best growth stocks for 2024 here. How do I buy shares of Small Pharma? Shares of DMT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:DMT) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Small Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.